CVE-2022-26596 — MEDIUM (6.1)

Q: How severe is CVE-2022-26596?

CVE-2022-26596 has been rated MEDIUM with a CVSS base score of 6.1/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2022-26596?

Check the references section above for vendor advisories and patch information. Affected products include: Liferay Digital Experience Platform, Liferay Liferay Portal.

Vulnerability Description

Cross-site scripting (XSS) vulnerability in Journal module's web content display configuration page in Liferay Portal 7.1.0 through 7.3.3, and Liferay DXP 7.0 before fix pack 94, 7.1 before fix pack 19, and 7.2 before fix pack 8, allows remote attackers to inject arbitrary web script or HTML via web content template names.

CVSS Score

6.1

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Liferay	Digital Experience Platform	7.0
Liferay	Liferay Portal	>= 7.1.0, <= 7.3.3

Related Weaknesses (CWE)

CWE-79

References

http://liferay.comVendor Advisory
http://liferay.comVendor Advisory

FAQ

What is CVE-2022-26596?

CVE-2022-26596 is a vulnerability with a CVSS score of 6.1 (MEDIUM). Cross-site scripting (XSS) vulnerability in Journal module's web content display configuration page in Liferay Portal 7.1.0 through 7.3.3, and Liferay DXP 7.0 before fix pack 94, 7.1 before fix pack 1...

How severe is CVE-2022-26596?

CVE-2022-26596 has been rated MEDIUM with a CVSS base score of 6.1/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2022-26596?

Check the references section above for vendor advisories and patch information. Affected products include: Liferay Digital Experience Platform, Liferay Liferay Portal.